Public Calendar: October 23-29, 2022

Public Calendar: October 23-29, 2022 Public Calendar: October 23-29, 2022 Anonymous (not verified) Fri, 11/04/2022 – 10:44

Detailed Description
Significant meetings held by FDA officials with persons outside of the executive branch of the federal government, October 23-29, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 10/24/2022
Location: Virtual
Subject: Food Industry Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Food and Beverage Issue Alliance

Event Date: 10/24/2022
Location: Virtual
Subject: Diagnostic Testing Issues
FDA Participant/Group: JEFFREY SHUREN;
Non FDA Participant/Group: Stakeholders from several academic medical centers

Event Date: 10/25/2022
Location: Washington, DC
Subject: Friends of Cancer Research 26th Annual Cancer Leadership Awards Reception
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Friends of Cancer Research, industry, academia, government and other invited guests

Event Date: 10/25/2022
Location: Boston, MA
Subject: Vision for the FDA
FDA Participant/Group: JEFFREY SHUREN; MICHAEL FELBERBAUM;
Non FDA Participant/Group: Several members of the Advanced Medical Technology Association Board

Event Date: 10/25/2022
Location: Boston, MA
Subject: The MedTech Conference; Fireside Chat
FDA Participant/Group: MICHAEL FELBERBAUM; JEFFREY SHUREN;
Non FDA Participant/Group: Government, academia, industry, media and other registered attendees

Event Date: 10/26/2022
Location: Plano, TX
Subject: Vision for the FDA
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members of the American Heart Association Board of Directors, staff and other invited guests

Event Date: 10/27/2022
Location: New York, NY
Subject: 2022 Galien Forum; Speaker: Keynote Address
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, academia, industry, media, and other registered attendees

Event Date: 10/28/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: JULIA TIERNEY; MARK RAZA; SUSAN MAYNE; TRISTAN COLONIUS; FRANK YIANNAS;
Non FDA Participant/Group: Allen Hubert, Monica Wilkins, Robert Ford (Abbott Laboratories);

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 10/25/2022
Location: Virtual
Subject: Data Standardization
FDA Participant/Group: RAM IYER; VIDYUT DESAI; JAMES MULHOLLAND; THOMAS BEACH; MEREDITH CHUK; MOHAMMED CHAUDHRY;
Non FDA Participant/Group: Jessica Wasserman (WassermanRowe); Kari Finch (General Mills); Alycia Sohn (American Association of Exporters and Importers (AAEI));

Event Date: 10/27/2022
Location: Virtual
Subject: Council for Federal Cannabis Regulation (CFCR) | FDA Webinar
FDA Participant/Group: N/A
Non FDA Participant/Group: CFCR members, industry, and other stakeholders

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 10/24/2022
Location: Salinas, CA
Subject: Leafy Greens and Food Safety Issues of Mutual Interest
FDA Participant/Group: JEFFREY FARRAR; KAREN MEISTER;
Non FDA Participant/Group: Representative Jimmy Panetta (D-CA) and staff, Representative Zoe Lofgren (D-CA) and staff, representatives from the California Leafy Green Products Handling Marketing Agreement, representatives from the California Department of Food and Agriculture, farmers, and food manufacturers

Event Date: 10/28/2022
Location: Virtual
Subject: Food Safety Culture
FDA Participant/Group: N/A
Non FDA Participant/Group: Anju Rao (Starbucks);

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 10/26/2022
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Jigar Raval (Indian Embassy);

Event Date: 10/27/2022
Location: Virtual
Subject: 11th Meeting of the WHO Member State Mechanism on Substandard and Falsified Medicines
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Pan American Health Organization

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 10/25/2022
Location: Virtual
Subject: 2022 C-Path Neuroscience Annual Meeting
FDA Participant/Group: JACQUELINE CORRIGAN CURAY;
Non FDA Participant/Group: Industry, academia, regulatory agencies, and other stakeholders

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 10/24/2022
Location: Boston, MA
Subject: Massachusetts Consortium on Pathogen Readiness Symposium – Illuminating Our Path Forward: Lessons from an Evolving Pandemic; Facilitating the Development and Availability of COVID-19 Vaccines
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Massachusetts Consortium on Pathogen Readiness Symposium

Event Date: 10/26/2022
Location: Virtual
Subject: Pharmaceutical Executive Summit; Gene Therapy – Unlocking the Promise
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of Pharmaceutical Executive Summit

Event Date: 10/27/2022
Location: New York, NY
Subject: Galien Forum 2022; Panelist: COVID Pandemic Science 2022: Current Vaccines and Treatments and the Future Outlook
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of Galien Forum 2022

Event Date: 10/28/2022
Location: Virtual
Subject: Alliance for Regenerative Medicine/FDA Liaison Meeting
FDA Participant/Group: SHERYL LARD WHITEFORD; ANITA RICHARDSON; WILSON BRYAN; RACHAEL ANATOL; CHRISTOPHER JONECKIS; MELISSA MENDOZA;
Non FDA Participant/Group: Representatives from the Alliance for Regenerative Medicine

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 10/26/2022
Location: Boston, MA
Subject: The MedTech Conference; CDRH Town Hall
FDA Participant/Group: ELI TOMAR; WILLIAM MAISEL; DOUGLAS KELLY; SUZANNE SCHWARTZ; MICHELLE TARVER;
Non FDA Participant/Group: Government, academia, industry, media and other registered attendees

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 10/24/2022
Location: Bethesda, MD
Subject: Tobacco Centers of Regulatory Science (TCORS) Fall Conference; Speaker
FDA Participant/Group: BRIAN KING;
Non FDA Participant/Group: Several representatives from the Tobacco Centers of Regulatory Science (TCORS)

Event Date: 10/26/2022
Location: Washington, DC
Subject: Update on FDA Product Standards
FDA Participant/Group: BRIAN KING;
Non FDA Participant/Group: Several representatives from the Council on Foreign Relations

Event Date: 10/26/2022
Location: Virtual
Subject: American Thoracic Society (ATS) Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from the American Thoracic Society (ATS)

Event Date: 10/26/2022
Location: Virtual
Subject: Health Canada Introductory Meeting
FDA Participant/Group: ESHAEL JOHNSON; PRISCILLA LYON; BRIAN KING; MEGAN HICKS;
Non FDA Participant/Group: Several representatives from Health Canada

Event Date: 10/27/2022
Location: Virtual
Subject: American Society for Clinical Oncology (ASCO) Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from American Society for Clinical Oncology (ASCO)

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 10/27/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives of the Generic Animal Drug Alliance (GADA)

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

Short Title
Public Calendar: October 23-29, 2022

Source Organization

Short Description
Significant meetings held by FDA officials with persons outside of the executive branch of the federal government, October 23-29, 2022

Publish Date
Fri, 11/04/2022 – 11:54

Review Date
Sat, 11/04/2023 – 10:00

Last Reviewed Date
Fri, 11/04/2022 – 10:00

Next Review Date
1 Year

Navigational Page
Off

Bulk Approved
Off

Display Short Description
Off

First Publish Date
Fri, 11/04/2022 – 11:54

Generic Boolean
Off

Language

Number of Related Information to Display
3

Add Subscription Box
Off

Display Short Title
Off

#CBD #Hemp http://www.fda.gov/news-events/public-calendar-meetings-fda-officials/public-calendar-october-23-29-2022 November 4, 2022 2:44 pm

বাংলা简体中文繁體中文EnglishFrançaisDeutschहिन्दीItaliano日本語한국어मराठीPortuguêsਪੰਜਾਬੀРусскийEspañolSvenskaతెలుగుไทยTürkçeУкраїнськаTiếng Việt